Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-04-25

Clinical Trial Update: Investigation of Genetic Predictors of the Response to Selective Serotonin Re-uptake Inhibitors (SSRI) Treatment [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating genetic predictors of response to SSRI treatment in major depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Tartu | Conditions: Major Depression | Phase 4 | Status: COMPLETED | Results posted: 2019-04-25